Centers & Programs
The Human Immune Monitoring Center
The Human Immune Monitoring Center (HIMC) is a new facility, jointly developed by the Institute of Immunology, Transplantation and Infectious Disease (ITI) and the Center of Clinical Immunology Sciences (CCIS). The laboratory is operational and is charged with developing and implementing assays that will monitor the health of the human immune system and to make these assays available to the Stanford Medical Research Community and others, as resources permit.
Center for Hepatitis and Liver Tissue Engineering
Hepatitis is an important worldwide cause of acute and chronic liver disease. Etiologies include toxins, drugs, and viruses. Viral hepatitis alone afflicts over half a billion people around the world. Among the responsible viruses are hepatitis A virus (HAV), hepatitis B virus (HBV), hepatitis C virus (HCV), and hepatitis D virus (HDV). Complications include fulminant liver failure, cirrhosis and hepatocellular carcinoma (HCC). Current therapies are inadequate for most infected patients, and the clinical needs are increasing.
The Center for Clinical Immunology at Stanford
Stanford scientist physicians are internationally renowned for their fundamental advances in the field of clinical immunology. Innovative strategies for immunotherapy for autoimmune diseases, bone marrow and stem cell transplantation, and organ transplantation tolerance have been developed and applied at Stanford. More basic breakthroughs in understanding cell-signaling pathways, lymphocyte biology and immune regulation have also occurred at Stanford.
The Stanford-LPCH Vaccine Program
Historically, vaccines against infectious agents have had a more profound impact on the health of the world's population than any other advance in the biomedical sciences. Vaccine research is entering an exciting phase of expansion and innovation which is expected to yield many new approaches to disease prevention and therapy that will be useful well beyond the traditional domain of infectious diseases.